Leukemia & lymphomaHumansMaleHematopoietic Stem Cell TransplantationMiddle AgedFemale
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia.
Benjamin McCormick, Anthony Findley, Kendall Diebold, Garrett Bourne, Maris Hardee, James Foran, Mohamed Kharfan-Dabaja, Hemant Murthy, Madiha Iqbal, Naseema Gangat, Lisa Sproat, Jeanne Palmer, William J Hogan, Kebede Begna, Mark Litzow
Published: 202510.1080/10428194.2025.2564766
Abstract
Allogeneic hematopoietic cell transplantation (allo-HCT) remains a key treatment for patients with chronic myeloid leukemia (CML) in blast phase (CML-BP) or tyrosine kinase inhibitor (TKI)-resistant chronic phase (CML-CP). We retrospectively analyzed…
Preview only. Read the full abstract at the source